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ABSTRACT 
 
STUDY OF KETOROLAC IN  
CLOSED FRACTURE PATIENTS 
(Research on Orthopaedic Cases at the Hospital of 
Universitas Airlangga Surabaya) 
  
Alin Aristiani 
 
Closed fracture is a bone disorder that occurs due to discontinuity of 
bone tissue and caused moderate to severe pain. Ketorolac is an NSAIDs 
non – selective COX inhibitor which is used to treat moderate to severe 
pain.  
This study was conducted  to determine the use of ketorolac (dose 
regimens and duration of use) and to identify Drug Related Problems. 
The study used descriptive analysis by collecting the retrospective 
data of orthopaedic patients admitted at the Hospital of Universitas 
Airlangga Surabaya on 1
st
 January 2014 until 31
st
 December 2017 which 
match the inclusion criteria. 
In this study, there are 62 patients that fullfilled inclusion criteria. 
Patients used ketorolac (3x30 mg) IV (11%), in combination two analgesics 
(13%), in three combination analgesics (3%), and switching ketorolac 
(73%). Ketorolac (3x30 mg) IV + metamizol (3x1 g) IV are used to treat 
mild pain and ketorolac (3x30 mg) IV + tramadol (3x100 mg) IV + 
metamizol (3x1 g) IV are used to treat moderate to severe pain.  
Closed fracture patients used ketorolac with a right dose, right route 
of administration, and  right duration of use (3x30 mg IV not exceed 5 
days). Drug Related Problems that identified in this study was actual 
adverse drug reaction (ketorolac + metamizol) caused nausea and 
abdominal pain. 
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